VERAXA completed its Nasdaq listing and finished the 1st day of trading at $24.79.
🎉 We’re proud to share that VERAXA Biotech begun trading on the Nasdaq Capital Market under ticker symbol "VRXA" on June 11, 2026.
Becoming a publicly traded company marks an exciting new chapter as we pioneer next-generation cancer therapies.
Our focus now: advancing toward key value inflection points and positioning our proprietary BiTAC platform as a launchpad for the next wave of cancer therapies.